Iatrogenic lesions of the female genital tract

Current Diagnostic Pathology

Volumn 9, Issue 2, 2003, Pages 105-113

  Cheung, A N Y ^a   Ip, P P C ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Assisted reproduction; Female genital tract; Iatrogenic lesions; Tamoxifen

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; ORAL CONTRACEPTIVE AGENT; PODOPHYLLIN; PROGESTERONE; TAMOXIFEN;

CONFERENCE PAPER; CONTRACEPTION; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC DISEASE; HUMAN; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFERTILITY THERAPY; INTRAUTERINE CONTRACEPTIVE DEVICE; NECROTIZING ARTERITIS; PATHOLOGY;

EID: 0037386984     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2003.0163     Document Type: Conference Paper

References (82)

1. Campbell JS, Napke E, Mikhael NZ et al. Iatrogenic disease of the female genital tract. In: Fox H (ed.). Haines and Taylor: Obstetrical and Gynaecological Pathology. Edinburgh: Churchill Livingstone, 1995;1183-1207.
2. Morris H. Surgical pathology of the lower uterine segment cesarean section scar: Is the scar a source of clinical symptoms: Int J Gynecol Pathol 1995; 14: 16-20.
3. Waxman M, Pardanani R. Implanted placental tissue simulating uterine fibroids ("inverted placental polyp"). Diag Gynecol Obstet 1980; 2: 287-289.
4. Evans CS, Goldman RL, Klein HZ et al. Necrobiotic granulomas of the uterine cervix: a probable postoperative reaction. Am J Surg Pathol 1984; 8: 841-844.
5. Akosa AB, Boret F. Necrotising granulomas of the uterine corpus. J Clin Pathol 1993; 46: 953-955.
6. Davies JD, Neely J. The histopathology of peritoneal starch granulomas. J Pathol 1972; 107: 265-278.
7. , Acharya V, Tolnai G, Campbell JS, Hooper DG. Letter: Maltese cross of surgery. Can Med Assoc J 1973; 109: 1183-1184.
8. Cooke SA, Hamilton DG. The significance of starch powder contamination in the etiology of peritoneal adhesions. Br J Surg 1977; 64: 410-412.
9. Grant JB, Davies JD, Jones JV, Espiner HJ, Eltringham WK. The immunogenicity of starch glove powder and talc. Br J Surg 1976; 63: 864-866.
10. Strate SM, Taylor WE, Forney JP, Silva FG. Xanthogranulomatous pseudotumor of the vagina: evidence of a local response to an unusual bacterium (mucoid Escherichia coli). Am J Clin Pathol 1983; 79:637-643.
11. Ghosh A. Lipogranuloma of the uterine parametrium. Br J Obstet Gynaecol 1976; 83: 409-410.
12. Kim RK, Scully RE. Peritoneal keratin granulomas with carcinomas of endometrium and ovary and atypical polypoid adenomyoma of endometrium. A clinicopathological analysis of 22 cases. Am J Surg Pathol 1990; 14: 925-932.
13. Neuwirth RS. Gynecologic surgery and adhesion prevention. Asherman's syndrome. Prog Clin Biol Res 1993; 381: 187-190.
14. Muram D, Drouin P. Ovarian remnant syndrome. Can Med Assoc J 1982; 127: 399-400.
15. Shemwell RE, Weed JC. Ovarian remnant syndrome. Obstet Gynecol 1970; 36: 299-303.
16. Silverberg SG, Frable WJ. Prolapse of fallopian tube into vaginal vault after hysterectomy. Histopathology, cytopathology, and differential diagnosis. Arch Pathol 1974; 97: 100-103.
17. Bilodeau B. Intravaginal prolapse of the fallopian tube following vaginal hysterectomy. Am J Obstet Gynecol 1982; 143: 970-971.
18. Wheelock JB, Schneider V, Goplerud DR et al. Prolapsed fallopian tube masquerading as adenocarcinoma of the vagina in a postmenopausal woman. Gynecol Oncol 1985; 21: 369-375.
19. Proppe KH, Scully RE, Rosai J et al. Postoperative spindle cell nodules of genitourinary tract resembling sarcomas: A report of eight cases. Am J Surg Pathol 1984; 8: 101-108.
20. Clement PB. Postoperative spindle cell nodule of the endometrium. Arch Pathol Lab Med 1988; 112: 566-568.
21. Manson CM, Hirsch PJ, Coyne JD et al. Post-operative spindle cell nodule of the vulva. Histopathol 1995; 26: 571-574.
22. Sadove AM, Block M, Rossof AH et al. Radiation carcinogenesis in man: new primary neoplasms in fields of prior therapeutic radiation. Cancer 1981; 48: 1139-1143.
23. Paik HH, Komorowski R. Hemangiosarcoma of the abdominal wall following irradiation therapy of endometrial carcinoma. Am J Clin Pathol 1976; 66: 810-814.
24. Mark RJ, Poen J, Tran LM et al. Postirradiation sarcoma of the gynecologic tract: A report of 13 cases and a discussion of the risk of radiation-induced gynecologic malignancies. Am J Clin Oncol 1996; 19: 59-64.
25. Patten SF Jr. Postradiation dysplasia of the uterine cervix: cytopatholgoy and clinical significance. In: Wied GL, Koss LG, Reagan J (eds). Compendium on Diagnostic Cytology. Chicago: University of Chicago; 268-274, 1988.
26. Koss LG. The effects of some therapeutic procedures and drugs on the epithelia of the female genital tract. In: Diagnostic Cytology and its Histopathologic Basis. Philadelphia: Lippincott, 1979; 510-528.
27. Buckley CH. Pathology of contraception and of hormonal therapy. In: Fox H (ed.). Haines and Taylor: Obstetrical and Gynecological Pathology. Edinburgh: Churchill Livingstone, 1995;1137-1182.
28. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713-1727.
29. Deligdisch L. Hormonal pathology of the endometrium. Mod Pathol 2000; 13: 285-294.
30. Goldzieher JW, Maqueo M, Ricaud L, Aguilar JA, Canales E. Induction of degenerative changes in uterine myomas by highdosage progestin therapy. Am J Obstet Gynecol 1966; 96: 1078-1087.
31. Norris HJ, Hilliard GD, Irey NS. Hemorrhagic cellular leiomyomas ("apoplectic leiomyoma") of the uterus associated with pregnancy and oral contraceptives. Int J Gynecol Pathol 1988; 7: 212-224.
32. Young RH, Scully RE. Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma. A report of five cases and review of the literature. Am J Surg Pathol 1989; 13: 50-56.
33. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international multicentre case-control study. Lancet 1996; 348: 505-510.
34. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet 1997; 349: 1202-1209.
35. Kaunitz AM. Reappearance of the intrauterine device: a "user-friendly" contraceptive. Int J Fertil Womens Med 1997; 42: 120-127.
36. Muller-Holzner E, Ruth NR, Abfalter E et al. IUD-associated pelvic actinomycosis: a report of five cases. Int J Gynecol Pathol 1995; 14: 70-74.
37. Gray Y, Libbey NP. Xanthogranulomatous salpingitis and oophoritis: a case report and review of the literature. Arch Pathol Lab Med 2001; 125: 260-263.
38. Dicker D, Feldberg D, Samuel N, Goldman JA. Etiology of cervical pregnancy: association with abortion pelvic pathology, IUDs and Asherman's syndrome. J Reprod Med 1985; 30: 25-27.
39. Ercal T, Cinar O, Mumcu A, Lacin S, Ozer E. Ovarian pregnancy; relationship to an intrauterine device. Aust N Z J Obstet Gynaecol 1997; 37: 362-364.
40. Marchbanks PA, Annegers JF, Coulam CB et al. Risk factors for ectopic pregnancies: a population based study. JAMA 1988; 259: 1823-1827.
41. Pisarska MD, Carson SA, Buster JE, Ectopic pregnancy. Lancet 1998;351: 1115-1120.
42. Nazari A, Askari HA, Check JH et al. Embryo transfer techniques as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril 1993; 60: 919-921.
43. Dietl J. Ovulation and ovarian cancer. Lancet 1991; 338: 445.
44. Banks E, Beral V, Reeves G. The epidemiology of epithelial ovarian cancer: a review. Int J Gynecol Cancer 1997; 7: 425-438.
45. Kosec V, Bukovic D, Grubisic G, Fures R. Ovarian cancer and ovulation induction drugs - is there a link? Coll Antropol 1999; 23: 633-639.
46. Goshen R, Weissman A, Shoham Z. Epithelial ovarian cancer, infertility and induction of ovulation: possible pathogenesis and updated concepts. Baillieres Clin Obstet Gynaecol 1998; 12: 581-591.
47. Artini PG, Fasciani A, Cela V et al. Fertility drugs and ovarian cancer. Gynecol Endocrinol 1997; 11: 59-68.
48. Benshushan A, Paltiel O, Brzezinski A et al. Ovulation induction and risk of endometrial cancer: a pilot study. Eur J Obstet Gynecol Reprod Biol 2001; 98: 53-57.
49. Goldstein SR. The effect of SERMs on the endometrium. Ann N Y Acad Sci 2001; 949: 237-242.
50. van Leeuwen FE, Benraadt J, Coebergh JW et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994; 343: 448-452.
51. Cohen I, Rosen DJ, Shapira J et al. Endometrial changes with tamoxifen: comparison between tamoxifen-treated and non-treated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 1994; 52: 185-190.
52. Ismail SM, The effects of tamoxifen on the uterus. Curr Opin Obstet Gynecol 1996; 8: 27-31.
53. Nuovo MA, Nuovo GJ, McCaffrey RM, Levine RU, Barron B, Winkler B. Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 1989; 8: 125-131.
54. Kedar RP, Bourne TH, Powles TJ et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994; 343: 1318-1321.
55. Seoud M, Shamseddine A, Khalil A et al. Tamoxifen and endometrial pathologies: a prospective study. Gynecol Oncol 1999; 75: 15-19.
56. Cardosi RJ, Fiorica JV. Surveillance of the endometrium in tamoxifen treated women. Curr Opin Obstet Gynecol 2000; 12: 27-31.
57. Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 2000; 78: 181-186.
58. Eltabbakh GH, Mount SL. Tamoxifen and the female reproductive tract. Expert Opin Pharmacother 2001; 2: 1399-1413.
59. Clement PB, Oliva E, Young RH. Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 1996; 15(3) 222-229.
60. Kaleli S, Calay Z, Altinok T, Kosebay D. Endometrial mixed Mullerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review. Eur J Obstet Gynecol Reprod Biol 2002; 101: 204-208.
61. Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet 2000; 356: 881-887.
62. Neven P, Goldstein SR, Ciaccia AV, Zhou L, Silfen SL, Muram D. The effect of raloxifene on the incidence of ovarian cancer in postmenopausal women. Gynecol Oncol 2002; 85: 388-90.
63. Robboy SJ. A hypothetic mechanism of diethylstilbestrol(DES)-induced anomalies in exposed progeny. Hum Pathol 1983; 14: 831-833.
64. Goldstein DP. Incompetent cervix in offspring exposed to diethylstilbestrol in utero. Obstet Gynecol 1978; 52: 73S-75S.
65. Kaufman RH, Adam E, Binder GL, Gerthoffer E. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol. 1980; 137: 299-308.
66. Herbst AL, Hubby MM, Azizi F, Makii MM. Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am J Obstet Gynecol 1981; 141: 1019-1028.
67. Herbst AL, Cole P, Colton T, Robboy SJ, Scully RE. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol 1977; 128: 43-50.
68. Herbst AL, Anderson D. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol 1990; 6: 343-346.
69. Kaminski PF, Maier RC. Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure. Obstet Gynecol 1983; 62: 720-727.
70. Fox H. Endometrial carcinogenesis and its relation to estrogens. Pathol Res Pract 1984; 179: 13-19.
71. Colgan TJ, Pendergast S, LeBlanc M. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Hum Pathol 1993; 24: 1073-1077.
72. Othman NH, Othman MS, Ismail AN, Mohammad NZ, Ismail Z. Multiple polypoid endometriosis - a rare complication following withdrawal of gonadotrophin releasing hormone (GnRH) agonist for severe endometriosis: a case report. Aust N Z J Obstet Gynaecol 1996; 36: 216-218.
73. Ansell ID, Evans DJ, Wight DG. Asymptomatic arteritis of the uterine cervix. J Clin Pathol 1974; 27: 664-668.
74. Wilansky R, MacLean JN, Miro R et al. Necrotizing vasculitis in gynecological surgery. Eur J Obstet Gynecol Reprod Biol. 1980; 10: 401-406.
75. Womack C. Isolated arteritis of the ovarian hilum. J Clin Pathol 1987; 40: 1484-1485.
76. Cordiner JW, Sharp F, Briggs JD. Cervical intraepithelial neoplasia in immunosuppressed women after renal transplantation. Scott Med J 1980; 25: 275-277.
77. Schneider V, Kay S, Lee HM. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983; 27: 220-224.
78. Alloub MI, Barr BB, McLaren KM, Smith IW, Bunney MH, Smart GE. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ 1989; 298: 153-156.
79. Sekiya S, Iwasaki H, Takeda B, Takamizawa H. Endometrial carcinoma following chronic anovulation in a premenopausal woman with systemic lupus erythematosus. Acta Obstet Gynecol Scand 1988; 67: 553-556.
80. Wade TR, Ackerman AB. The effects of resin of podophyllin on condyloma acuminatum. Am J Dermatopathol 1984; 6: 109-122.
81. Matias Guiu X, Lerma E, Prat J. Clear cell tumors of the female genital tract. Semin Diagn Pathol 1997; 14: 233-239.
82. Yokoyama S, Kashima K, Inoue S, Daa T, Nakayama I, Moriuchi A. Biotin-containing intranuclear inclusions in endometrial glands during gestation and puerperium. Am J Clin Pathol 1993; 99: 13-17.